Package 59651-314-77

Brand: tizanidine hydrochloride

Generic: tizanidine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 59651-314-77
Digits Only 5965131477
Product NDC 59651-314
Product ID 59651-314_c5462b0a-179b-449f-87e9-1ccfa18367b3
Description

150 CAPSULE in 1 BOTTLE (59651-314-77)

Marketing

Marketing Status
Marketed Since 2020-03-24
Brand tizanidine hydrochloride
Generic tizanidine hydrochloride
Sample Package No

Linked Drug Pages (1)

Tizanidine Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c5462b0a-179b-449f-87e9-1ccfa18367b3", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["485484", "485485", "485486"], "spl_set_id": ["19cf46b5-d8dc-44cb-83d6-bacea0870dbe"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE in 1 BOTTLE (59651-314-77)", "package_ndc": "59651-314-77", "marketing_start_date": "20200324"}], "brand_name": "Tizanidine Hydrochloride", "product_id": "59651-314_c5462b0a-179b-449f-87e9-1ccfa18367b3", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "59651-314", "generic_name": "Tizanidine Hydrochloride", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine Hydrochloride", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA213544", "marketing_category": "ANDA", "marketing_start_date": "20200324", "listing_expiration_date": "20261231"}